journal article·2021-04-12

Multiscale Synchrotron-Based Imaging Analysis for the Transfer of PEGylated Gold Nanoparticles In Vivo

Xue Li, Hongyang Yu, Bing Wang, Wei Chen, Meilin Zhu, Shanshan Liang, Runxuan Chu, Shuang Zhou, Hanqing Chen, Meng Wang, Lingna Zheng, Weiyue Feng

Publisher page

Abstract

High spatial resolution imaging analysis is urgently needed to explore the biodistribution, transfer and clearance profiles, and biological impact of nanoparticles in the body, which will be helpful to clarify the efficacy of nanomedicine in clinical applications. Herein, by combination with multiscale synchrotron-based imaging techniques, including X-ray fluorescence (XRF) spectrometry, Fourier transform infrared (FTIR) spectroscopy, and micro X-ray phase contrast computed tomography (micro-XPCT), we visually displayed the transfer patterns and site-specific distribution of PEGylated gold nanoparticles (PEG-GNPs) in the suborgans of the liver, spleen, and kidney after an intravenous injection in mice. A combination of XRF and FTIR imaging analysis showed that the PEG bands presented similar distribution patterns with Au in the intraorgans, suggesting the stability of PEGylation on GNPs. We show that the PEG-GNPs presented heterogeneous distribution in the hepatic lobules with a large amount around the portal vein zone and then a gradient decrease in the sinusoidal region and the CV zone; in the spleen, it gradually accumulated in the splenic red pulp over time; and in the kidney, it quickly transported via the bloodstream to the renal pyramids and renal pelvis, and parts of PEG-GNPs finally accumulated in the renal medulla and renal cortex. Multidimensional micro-XPCT images further show that the PEG-GNP transfer in the liver induced hepatic blood vessel dilatation while they transferred in the liver, providing evidence of GNP transport across the blood vessel endothelial barrier.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS-HKU Joint Laboratory of Metallomics on Health & Environment, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China

University of Chinese Academy of Sciences, Beijing 100049, China

Institute of Health Sciences, Anhui University, Hefei, Anhui 230601, China

Department of Gastroenterology, Guangzhou Digestive Disease Center, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.1021/acsnano.6b0604010.1021/acsnano.6b06040 ↗
2. 10.1038/s41565-020-0759-510.1038/s41565-020-0759-5 ↗
3. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
4. 10.1073/pnas.110527010810.1073/pnas.1105270108 ↗
5. 10.1002/adma.20170430710.1002/adma.201704307 ↗
6. 10.1021/acs.chemrev.8b0073310.1021/acs.chemrev.8b00733 ↗
7. 10.1002/adma.20180574010.1002/adma.201805740 ↗
8. 10.1021/acsnano.9b0011410.1021/acsnano.9b00114 ↗
9. 10.1007/s11426-015-5394-x10.1007/s11426-015-5394-x ↗
10. 10.1039/B921201A10.1039/B921201A ↗
11. 10.1021/nl201391e10.1021/nl201391e ↗
12. 10.1073/pnas.100319810710.1073/pnas.1003198107 ↗
13. 10.1371/journal.pone.002129710.1371/journal.pone.0021297 ↗
14. 10.1016/j.electacta.2017.07.08910.1016/j.electacta.2017.07.089 ↗
15. 10.1007/s00216-016-9646-110.1007/s00216-016-9646-1 ↗
16. 10.1107/S090904951003125010.1107/S0909049510031250 ↗
17. 10.1039/c2mt00104g10.1039/c2mt00104g ↗
18. 10.1039/C5CS00515A10.1039/C5CS00515A ↗
19. 10.1080/05704928.2016.123086310.1080/05704928.2016.1230863 ↗
20. 10.1039/C4AN01982B10.1039/C4AN01982B ↗
21. 10.1038/physci241020a010.1038/physci241020a0 ↗
22. 10.1021/nn201624c10.1021/nn201624c ↗
23. 10.1021/acsami.9b1591010.1021/acsami.9b15910 ↗
24. 10.1021/acsnano.9b0974410.1021/acsnano.9b09744 ↗
25. 10.1186/s12951-020-00599-110.1186/s12951-020-00599-1 ↗
26. 10.1016/j.impact.2020.10025910.1016/j.impact.2020.100259 ↗
27. 10.1038/nmat471810.1038/nmat4718 ↗
28. 10.1021/jacs.5b0989510.1021/jacs.5b09895 ↗
29. 10.1016/j.vph.2015.05.01610.1016/j.vph.2015.05.016 ↗
30. 10.1021/acsnano.9b0812710.1021/acsnano.9b08127 ↗
31. 10.1002/adtp.20190017010.1002/adtp.201900170 ↗
32. 10.1016/j.ejps.2016.06.00710.1016/j.ejps.2016.06.007 ↗
33. 10.1038/ncomms1453710.1038/ncomms14537 ↗
34. 10.1002/smll.20110170810.1002/smll.201101708 ↗
35. 10.2174/092986732666619012914260410.2174/0929867326666190129142604 ↗
36. 10.1007/s00204-021-02992-710.1007/s00204-021-02992-7 ↗
37. 10.1039/D0NH00333F10.1039/D0NH00333F ↗
38. 10.1152/ajpheart.1990.258.2.H46010.1152/ajpheart.1990.258.2.H460 ↗
39. 10.1021/acsnano.5b0648710.1021/acsnano.5b06487 ↗
40. 10.1021/acsnano.7b0174410.1021/acsnano.7b01744 ↗
41. 10.1038/ncomms265510.1038/ncomms2655 ↗
42. 10.1038/s41565-018-0356-z10.1038/s41565-018-0356-z ↗
43. 10.1039/C9CS00309F10.1039/C9CS00309F ↗